PubRank
Search
About
Marshall Z Schwartz
Author PubWeight™ 14.55
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease.
J Pediatr Surg
2004
0.99
2
Modulation of the inflammatory response and apoptosis using epidermal growth factor and hepatocyte growth factor in a liver injury model: a potential approach to the management and treatment of cholestatic liver disease.
J Pediatr Surg
2008
0.90
3
Vacuum-assisted closure in the treatment of extensive lymphangiomas in children.
J Pediatr Surg
2012
0.87
4
Early experience with single-incision thoracoscopic surgery in the pediatric population.
J Laparoendosc Adv Surg Tech A
2010
0.86
5
Leptin: a new growth factor for the small intestine.
J Pediatr Surg
2002
0.84
6
IL-11 pretreatment reduces cell death after intestinal ischemia-reperfusion.
J Surg Res
2002
0.83
7
Hepatocyte growth factor pretreatment reduces apoptosis and mucosal damage after intestinal ischemia-reperfusion.
J Pediatr Surg
2002
0.81
8
Intralobar pulmonary sequestration: an uncommon case with triple arterial supply and systemic venous drainage.
Pediatr Surg Int
2012
0.80
9
Single-incision thoracoscopic surgery in children: equivalent results with fewer scars when compared with traditional multiple-incision thoracoscopy.
J Laparoendosc Adv Surg Tech A
2011
0.80
10
A comparison of laparoscopic and open Nissen fundoplication and gastrostomy placement in the neonatal intensive care unit population.
J Pediatr Surg
2010
0.79
11
Hepatocyte growth factor and omega-3-enriched feeds have a synergistic effect on mucosal mass in an animal model of inflammatory bowel disease.
J Pediatr Surg
2012
0.78
12
The effect of hepatocyte growth factor on gene transcription during intestinal adaptation.
J Pediatr Surg
2011
0.77
13
Hepatocyte growth factor ameliorates inflammatory bowel disease in a rat model.
J Gastrointest Surg
2003
0.77
14
Interleukin-11 enhances intestinal absorptive function after ischemia-reperfusion injury.
J Pediatr Surg
2002
0.77
15
Dose variation of hepatocyte growth factor and its effects on an animal model of TPN-induced liver injury.
J Surg Res
2010
0.77
16
Glucagonlike peptide-2 analogue: a possible new approach in the management of inflammatory bowel disease.
J Pediatr Surg
2004
0.77
17
Chronology of the effect of massive small bowel resection and hepatocyte growth factor (HGF) on intestinal adaptation.
J Surg Res
2011
0.77
18
Gene alterations and intestinal mucosal changes following growth factor and omega-3 exposure in a rat model of inflammatory bowel disease.
J Pediatr Surg
2013
0.77
19
Growth factor manipulation of intestinal angiogenesis: a possible new paradigm in the management of inflammatory bowel disease.
J Surg Res
2009
0.75
20
Successful endovascular repair of exsanguinating penetrating carotid artery injury in two pediatric patients.
Pediatr Surg Int
2015
0.75
21
Hepatocyte growth factor increases glucagon immunoreactivity in jejunal cells during intestinal adaptation.
J Pediatr Surg
2006
0.75
22
Proteasome gene upregulation: a possible mechanism for intestinal adaptation.
J Pediatr Surg
2005
0.75
23
Prophylactic antibiotics do not decrease the incidence of wound infections after laparoscopic pyloromyotomy.
J Pediatr Surg
2011
0.75
24
Transfection of the sodium/glucose cotransporter into colon mucosa: a novel treatment for short bowel syndrome.
J Pediatr Surg
2002
0.75
25
Growth factor modulation of hepatic inflammation: a novel approach to the management of total parenteral nutrition-associated liver disease.
J Pediatr Surg
2010
0.75
26
Study of an ovarian sclerosing stromal tumor presenting as vaginal bleeding in a 7-month-old.
Pediatr Dev Pathol
2007
0.75
27
Terminal ileal atresia, total colonic aganglionosis, and thrombophilia.
Pediatr Dev Pathol
2009
0.75
28
A possible mechanism for prevention of intestinal programmed cell death after ischemia-reperfusion injury by hepatocyte growth factor pretreatment.
J Pediatr Surg
2002
0.75
29
A rare cause of vaginal bleeding in a 7-month-old female infant.
J Pediatr Surg
2008
0.75